‘Highjack’ Autoimmunity to Enhance Efficacy of Immunotherapy?

Bryant Furlow of Cancer Network reports on recent research published in Cell Systems and suggests that “tumors can be rendered susceptible by ‘hijacking’ immune cell recruitment signals through molecular master regulators” noted Angela M. Christiano, PhD, of the Herbert Irvine Comprehensive Cancer Center, Columbia University Medical Center, New York.

As quoted the Columbia researchers:  “[W]e propose a strategy for enhancing cancer immunotherapy that entails ‘hijacking’ the molecular mechanisms that activate the immune system in autoimmune disease and using them to essentially ‘tag’ evasive tumors for immune-mediated destruction. We reasoned that the molecular processes that encourage active immune cell infiltration to the target organs in autoimmune disease could be used to restore immune targeting against cancer cells.”

Angela M. Christiano profile

Herbert Irvine Comprehensive Cancer Center, Columbia University Medical Center,  Department of Genetics and Development

View article here...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee